Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites.
about
Role of NLRP3 Inflammasome in the Progression of NAFLD to NASHMetabolic Inflammation-Differential Modulation by Dietary ConstituentsTreatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directionsGenetic, metabolic and environmental factors involved in the development of liver cirrhosis in MexicoPharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell PhenotypeNon-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentTargeting autophagy for the treatment of liver diseasesDistinct Hepatic Macrophage Populations in Lean and Obese MiceDefinitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic ReviewMolecular Pathogenesis of NASHRole of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and HumansRecent advances in understanding/management of non-alcoholic steatohepatitis.Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat DietAggravation of nonalcoholic steatohepatitis by moderate alcohol consumption is associated with decreased SIRT1 activity in ratsA mixture of apple pomace and rosemary extract improves fructose consumption-induced insulin resistance in rats: modulation of sarcolemmal CD36 and glucose transporter-4Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisLipidomics for studying metabolismMacrophage function in obesity-induced inflammation and insulin resistance.The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.Inflammation in nonalcoholic steatohepatitis.Effects of resveratrol in experimental and clinical non-alcoholic fatty liver diseaseβ-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in miceRole of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH)Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet.Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis.Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease.Molecular pathways in non-alcoholic fatty liver disease.Translational approaches: from fatty liver to non-alcoholic steatohepatitis.Tumor necrosis factor α-converting enzyme inhibition reverses hepatic steatosis and improves insulin sensitivity markers and surgical outcome in miceMetabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.Uncoupling protein 2 regulates palmitic acid-induced hepatoma cell autophagy.Carotid body denervation prevents fasting hyperglycemia during chronic intermittent hypoxiaRole of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet.FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.Metabolic consequences of high-fat diet are attenuated by suppression of HIF-1α.Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling.Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosisRecent advances in the development of farnesoid X receptor agonistsCurrent and upcoming pharmacotherapy for non-alcoholic fatty liver disease.
P2860
Q26742102-7A8D9F11-5198-4B6B-AF69-20C32602E51DQ26748868-26BD79AE-BEA2-4EBD-B2FB-B1A8788D5071Q26751258-A3BF5A59-9B1B-4FE4-8E22-689C72959F7EQ26778035-CA948E69-FD51-4B57-993D-174278E71EC7Q26779198-A29676E3-AB69-45D9-BF4F-9BE4CF9B3415Q26852019-B05BC1BB-8BAF-4389-950A-55DE49C932AAQ27014838-6ADE001C-C71A-4B73-9615-AEF95BCFC14AQ28069725-34EFE3B8-1790-4314-8FBB-DC65DF94D956Q28070408-AB2D037A-7F77-4710-A287-2ADA2D14AD12Q28071265-181B1316-9AB3-4B85-A906-0E73B6C2138CQ28075256-9279671A-AEE0-402F-96DE-5CACEF04B36AQ28085689-2B0E800C-B913-4856-9509-5BCD84007418Q28354293-BE79381A-141D-42A2-87DD-69B52B048CF1Q28573665-BAC30B09-883D-4A3D-963F-63D55CAC4F7BQ28598286-1F07D798-00DE-4CEB-B436-8A8EB6AA893CQ28607750-CDA3C3F9-AA9E-411B-B6A5-EAECE76608DAQ28802472-F6928712-78C2-4C43-A03D-042ACE7E3B40Q30235587-9A047787-E269-4880-89F9-7100847EF765Q30382395-281A289B-A2AA-429E-BE7B-CB2EEBDA0DD7Q30453231-523DD64C-CD3E-4E21-9ACC-2901D7508C3CQ33563877-A8E989E7-4C6D-4512-A51D-C9D84A31E34CQ33654923-AEBEEB0E-0940-4315-A052-CABE1E7CC5CCQ33665070-766477A2-5F9D-4718-BD5C-CEA05A07D95FQ33700432-A180DD0D-6AD3-4515-9FE1-B614D4D43853Q33755829-C2E7989E-6C56-40F7-BC57-E3E07C0F28E2Q33759921-D28BFE9C-C5B2-4D66-864B-DC2EFD5D7F65Q33862990-DD7B834D-2BB3-45B2-9E42-1A609522F52DQ33890230-3EB066B8-C2DC-4BD4-A138-BC67B1BC3F65Q33958697-10B8A306-1D89-4FA1-8D82-F7AC79DD8CD8Q34043373-177E7D3C-DE6F-4A3D-9EB8-3283D6187CCDQ34077811-975191F4-3212-4622-A3A4-241F9C79FB00Q34085090-E8070D23-D4C8-4B02-9B5B-BBA92E8B7292Q34295327-2FAFA905-2725-4D46-8919-845D500F8761Q34302360-160DB846-F6F2-4CCE-914F-52AA3C4ABDA7Q34366966-434CBB73-D448-49D1-96EB-4E530FA8BFD8Q34437691-729B1AE6-AD1D-4564-9602-E7FF236C9C12Q34446469-4F694B52-A9D8-408E-B5FA-C7E95E3078A4Q34447251-0ECECD35-C9A2-4653-924E-4808F46CA41BQ34464043-559A2123-4CDF-4C76-821D-2737BCC6AB30Q34540703-A8B6EE32-215A-4882-9398-4A8893047F4E
P2860
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatic lipotoxicity and the p ...... ceride fatty acid metabolites.
@en
Hepatic lipotoxicity and the p ...... ceride fatty acid metabolites.
@nl
type
label
Hepatic lipotoxicity and the p ...... ceride fatty acid metabolites.
@en
Hepatic lipotoxicity and the p ...... ceride fatty acid metabolites.
@nl
prefLabel
Hepatic lipotoxicity and the p ...... ceride fatty acid metabolites.
@en
Hepatic lipotoxicity and the p ...... ceride fatty acid metabolites.
@nl
P921
P356
P1433
P1476
Hepatic lipotoxicity and the p ...... ceride fatty acid metabolites.
@en
P2093
Brent A Neuschwander-Tetri
P304
P356
10.1002/HEP.23719
P407
P577
2010-08-01T00:00:00Z